Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial.

von Blanckenburg P, Schuricht F, Albert US, Rief W, Nestoriuc Y.

BMC Cancer. 2013 Sep 18;13:426. doi: 10.1186/1471-2407-13-426.

2.

Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study.

Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky AJ, Hadji P, Albert US, Rief W.

Ann Oncol. 2016 Oct;27(10):1909-15. doi: 10.1093/annonc/mdw266. Epub 2016 Aug 22.

PMID:
27551051
3.

Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.

Kool M, Fontein DB, Meershoek-Klein Kranenbarg E, Nortier JW, Rutgers EJ, Marang-van de Mheen PJ, van de Velde CJ.

Breast. 2015 Jun;24(3):224-9. doi: 10.1016/j.breast.2015.01.010. Epub 2015 Feb 20.

PMID:
25704982
4.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
5.

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.

Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D.

Breast Cancer Res Treat. 1999 May;55(2):189-99.

PMID:
10481946
6.

Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer.

Corter AL, Findlay M, Broom R, Porter D, Petrie KJ.

Br J Health Psychol. 2013 Feb;18(1):168-81. doi: 10.1111/bjhp.12003. Epub 2012 Nov 8.

PMID:
23134580
7.

Disentangling breast cancer patients' perceptions and experiences with regard to endocrine therapy: nature and relevance for non-adherence.

Wouters H, van Geffen EC, Baas-Thijssen MC, Krol-Warmerdam EM, Stiggelbout AM, Belitser S, Bouvy ML, van Dijk L.

Breast. 2013 Oct;22(5):661-6. doi: 10.1016/j.breast.2013.05.005. Epub 2013 Jun 14.

8.

Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer.

Taira N, Iwata H, Hasegawa Y, Sakai T, Higaki K, Kihara K, Yamaguchi T, Ohsumi S, Shimozuma K, Ohashi Y.

Breast Cancer Res Treat. 2014 May;145(1):155-64. doi: 10.1007/s10549-014-2935-5. Epub 2014 Apr 2.

PMID:
24692082
9.

Telehealth system (e-CUIDATE) to improve quality of life in breast cancer survivors: rationale and study protocol for a randomized clinical trial.

Galiano-Castillo N, Ariza-García A, Cantarero-Villanueva I, Fernández-Lao C, Díaz-Rodríguez L, Legerén-Alvarez M, Sánchez-Salado C, Del-Moral-Avila R, Arroyo-Morales M.

Trials. 2013 Jun 22;14:187. doi: 10.1186/1745-6215-14-187.

10.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Goel S, Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Review.

PMID:
19821328
11.

Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).

Hind D, Wyld L, Beverley CB, Reed MW.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004272. Review.

PMID:
16437480
12.

The effects of psychoeducation and telephone counseling on the adjustment of women with early-stage breast cancer.

Sherman DW, Haber J, Hoskins CN, Budin WC, Maislin G, Shukla S, Cartwright-Alcarese F, McSherry CB, Feurbach R, Kowalski MO, Rosedale M, Roth A.

Appl Nurs Res. 2012 Feb;25(1):3-16. doi: 10.1016/j.apnr.2009.10.003. Epub 2010 May 6.

PMID:
20974079
13.

Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.

Colleoni M, Munzone E.

Drugs. 2015 Aug;75(12):1311-21. doi: 10.1007/s40265-015-0433-7. Review.

PMID:
26177891
14.

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.

Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S.

Lancet Oncol. 2015 Oct;16(13):1380-8. doi: 10.1016/S1470-2045(15)00135-7. Epub 2015 Sep 9.

PMID:
26363985
15.

The influence of endocrine treatments for breast cancer on health-related quality of life.

Buijs C, de Vries EG, Mourits MJ, Willemse PH.

Cancer Treat Rev. 2008 Nov;34(7):640-55. doi: 10.1016/j.ctrv.2008.04.001. Epub 2008 Jun 2. Review.

PMID:
18514425
16.

Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence.

Heisig SR, Shedden-Mora MC, von Blanckenburg P, Schuricht F, Rief W, Albert US, Nestoriuc Y.

Psychooncology. 2015 Feb;24(2):130-7. doi: 10.1002/pon.3611. Epub 2014 Jun 21.

PMID:
24953538
17.

Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study.

Cao A, Zhang J, Liu X, Wu W, Liu Y, Fan Z, Zhang A, Zhou T, Fu P, Wang S, Ouyang Q, Tang J, Jiang H, Zhang X, Pang D, He J, Shi L, Wang X, Sheng Y, Mao D, Shao Z.

Health Qual Life Outcomes. 2016 Mar 24;14:51. doi: 10.1186/s12955-016-0446-2.

18.

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D.

J Natl Cancer Inst. 2001 Jul 4;93(13):979-89. Review.

PMID:
11438563
19.

Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?

Güth U, Myrick ME, Schötzau A, Kilic N, Schmid SM.

Breast Cancer Res Treat. 2011 Oct;129(3):799-807. doi: 10.1007/s10549-011-1668-y. Epub 2011 Jul 13.

PMID:
21750963
20.

Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.

Cella D, Fallowfield LJ.

Breast Cancer Res Treat. 2008 Jan;107(2):167-80. Epub 2007 Sep 18. Review.

PMID:
17876703

Supplemental Content

Support Center